Abstract
The perivascular sphingosine 1-phosphate signaling axis may be an emerging therapeutic target for treating chronic kidney disease (Tanaka et al.).
Original language | English (US) |
---|---|
Pages (from-to) | eadd2826 |
Journal | Science translational medicine |
Volume | 14 |
Issue number | 658 |
DOIs | |
State | Published - Aug 17 2022 |
ASJC Scopus subject areas
- Medicine(all)